Neil Woodford

Invesco Perpetual's income stalwart Neil Woodford has initiated three new positions in his £915m Edinburgh investment trust, to take advantage of share weakness.

Neil Woodford's heavy overweight pharmaceutical position on the Invesco Perpetual Income fund dragged the portfolio into the bottom quartile during the first three months of the year.

Moody's has downgraded Tesco's debt rating after warning it will "take time to revive profit growth" at the UK's largest supermarket.

Neil Woodford has for the first time lifted the lid on why he completely sold out of retailer Tesco, while admitting he was disinclined to do so with the stock trading at distressed valuations.

Neil Woodford's love of pharmaceutical companies has been well publicised over the past few years, but the income investor has been particularly excited about the prospects of a company using pieces of pig to regrow human tissue.

Invesco Perpetual's income stalwart Neil Woodford remains convinced pharmaceuticals are the buy of the decade, stating the sector is now the cheapest it has ever traded.

Asset managers and business leaders including Neil Woodford and Terry Leahy have criticised short-termism among UK investors and warned it is a threat to equity markets.

Invesco Perpetual's Neil Woodford has revealed he sold out of his Tesco holding after the firm's profit warning last month, just as veteran investor Warren Buffett was snapping up the stock.

AstraZeneca, a stalwart of many income portfolios including Neil Woodford's, has said it will raise its dividend by 10% despite sounding an earnings warning for 2012.

Neil Woodford has delivered a blow to European markets' positive start to the year, warning the eurozone is on the brink of entering recession.